Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK urged to keep TB controls tight, as "major problem" persists

This article was originally published in Clinica

Executive Summary

UK efforts to control TB must be sustained in order to tackle what remains a "major public health problem". So said the Health Protection Agency (HPA), after announcing a marginal annual fall in new cases last year, from 8,495 in 2006, to 8,417 (-0.9%). "The upward trend in recent years is beginning to stabilise, but the figures are still too high," it said, noting that in 2000, new case reports numbered 6,726. The problem is most acute among certain areas and population groups, notably inner cities: London alone, with 39% (3,265) of UK cases, had a prevalence rate of 43.2 per 100,000, compared with a national average of 8.4 per 100,000.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel